Education
About Us
Working with TipRanks
Follow Us
Senti Biosciences (SNTI)
NASDAQ:SNTI
Total Valuation
Senti Biosciences has a market cap or net worth of $36.10M. The enterprise value is $64.77M.
Market Cap$36.10M
Enterprise Value$64.77M
Share Statistics
Senti Biosciences has 26,160,206 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding26,160,206
Owned by Insiders66.18%
Owned by Institutions22.70%
Financial Efficiency
Senti Biosciences’s return on equity (ROE) is -2.06 and return on invested capital (ROIC) is -68.32%.
Return on Equity (ROE)-2.06
Return on Assets (ROA)-0.54
Return on Invested Capital (ROIC)-68.32%
Return on Capital Employed (ROCE)-0.72
Revenue Per Employee0.00
Profits Per Employee-1.55M
Employee Count34
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Senti Biosciences is ―. Senti Biosciences’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value0.63
Price to FCF―
Price to Operating Cash Flow-0.77
PEG Ratio―
Income Statement
In the last 12 months, Senti Biosciences had revenue of 0.00 and earned -52.79M in profits. Earnings per share was -11.49.
Revenue0.00
Gross Profit0.00
Operating Income-61.04M
Pretax Income-52.79M
Net Income-52.79M
EBITDA-46.94M
Earnings Per Share (EPS)-11.49
Cash Flow
In the last 12 months, operating cash flow was -48.49M and capital expenditures -207.00K, giving a free cash flow of -48.70M billion.
Operating Cash Flow-48.49M
Free Cash Flow-48.70M
Free Cash Flow per Share-1.86
Dividends & Yields
Senti Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.97
52-Week Price Change-51.57%
50-Day Moving Average1.81
200-Day Moving Average3.23
Relative Strength Index (RSI)28.01
Average Volume (3m)133.11K
Important Dates
Senti Biosciences upcoming earnings date is Nov 12, 2025, After Close (Confirmed).
Last Earnings DateAug 7, 2025
Next Earnings DateNov 12, 2025
Ex-Dividend Date―
Financial Position
Senti Biosciences as a current ratio of 4.49, with Debt / Equity ratio of 127.01%
Current Ratio4.49
Quick Ratio4.49
Debt to Market Cap0.29
Net Debt to EBITDA0.31
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Senti Biosciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Senti Biosciences EV to EBITDA ratio is -0.03, with an EV/FCF ratio of -0.04.
EV to Sales0.00
EV to EBITDA-0.03
EV to Free Cash Flow-0.04
EV to Operating Cash Flow-0.04
Balance Sheet
Senti Biosciences has $21.58M in cash and marketable securities with $31.31M in debt, giving a net cash position of $9.73M billion.
Cash & Marketable Securities$21.58M
Total Debt$31.31M
Net Cash$9.73M
Net Cash Per Share$0.37
Tangible Book Value Per Share$11.04
Margins
Gross margin is 24.80%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin24.80%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Senti Biosciences is $8.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$8.50
Price Target Upside515.94% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast-100.00%
EPS Growth Forecast29.21%